Core Insights - The strategic partnership between Dian Diagnostics and Hangzhou Data Group aims to establish a trusted data space in Hangzhou, marking Dian Diagnostics as the only third-party medical diagnostics company among the initial collaborators [2][4] - Dian Diagnostics has launched 16 data products on the Hangzhou Data Exchange platform, including datasets for cervical cancer screening, infection system diseases, vitamin D, coenzyme Q10, and allergens [2][3] - The company has accumulated 20PB of medical testing data from over 22,000 medical institutions, covering various fields such as oncology, infections, chronic diseases, and maternal and child health [2][3] Data Processing and Application - The data handling process consists of four stages: data collection and generation, preprocessing and storage, analysis and mining, and application and monetization [3] - The partnership focuses on building data infrastructure for the medical diagnostics industry, creating high-quality datasets, and developing AI medical products [4] - Future plans include expanding the monetization of data assets through financial innovation tools and exploring the value realization of medical testing data across various sectors, including clinical diagnosis, public health decision-making, and personal health management [4]